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Abstract
The total amount of waste drugs is expanding
significantly as populations age and societies become
wealthier. Drug waste is becoming a problem for
health and environment. Thus, how to reduce and
effectively dispose of waste drugs is increasingly
becoming an issue for society. In this paper, we
analyze the current situation with regard to existing
systems for expired drug recycling and disposal in
China and suggest that by connecting the involved
practices of waste drug recycling, medication
management, and household drug management the
incentives to participate in an integrated drug
recycling system can be dramatically increased for all
involved actors. This is important from an IS
perspective because such connecting of practices could
account for a novel mechanism of information
infrastructure emergence, known from physics as ‘state
transition’. By contrast, the current literature focuses
on the development of information infrastructures
through growth at the periphery, mostly driven by user
activity and enabled by modular and flexible designs.
Our approach could explain the de-novo emergence of
an information infrastructure.

1. Introduction
Household waste medicines refers to medicine
waste residing within homes [1]. Such waste does not
only cause economic loss but has also an adverse
impact on the environment and on human health if the
waste is improperly disposed of [2]. Specifically,
medical substances have been detected in sewage
effluents [3, 4], surface water [5], groundwater, and
even drinking water [6]. Safety is also compromised
when medicines fall into the hands of children or of
individuals who wish to abuse the medicines
themselves or to sell expired medicines on a “grey”
market.
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In China, storing drugs for emergent use in homes
in large quantities and varieties has become a common
practice. With the rapid economic and social
development of society the total amount of household
waste drugs is expanding significantly. In 2014, a
survey showed that about 78.6% of families in China
have the habit of storing prescription medicine and
more than 80% of the families do not regularly purge
their stock from expired medicines and even fewer
people know how to properly dispose of the expired
medicine [7]. The survey also showed that 72.5% of
families throw expired drugs into regular household
waste, 5% flush them down the toilet or drain, and 6%
of families even continue to use them. Therefore, how
to dispose of expired drugs has become an important
issue for government and society. However, systems
and processes for recycling expired drugs are still in an
early stage in China. Although the government and
some enterprises have implemented such processes and
systems, most of these activities are carried out by
public welfare organizations with government playing
only a promoting and guiding role, which tends to be
ineffective with regard to coordinating various
stakeholders and to be limited in duration and range. In
the current recycling regime, there are no obligations
or incentives for enterprises to collect and for
consumers to return expired drugs. Thus, it is urgent to
ask how to effectively reduce and dispose of expired
drugs through better coordination among the various
actors involved in drug-related activities.
The accumulation of expired drugs in family homes
is the result of a number of factors encompassing: (1)
patients recovering before their dispensed medicines
have all been taken; (2) therapies being stopped or
changed because of ineffectiveness and/or unwanted
side effects; (3) patients’ deaths; (4) factors relating to
repeat prescribing and dispensing processes [8].
Pharmaceuticals are special and therefore cannot be
treated like other commodities [9]. Reasons for the
special character of drugs include the high cost and
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long duration of research and development and the
repercussions of the product not being available. This
special character of drugs has implications for how to
properly deal with expired drugs. On the one hand,
expired drugs, when remaining unopened in their
original container, would be expected to remain stable
for an average of 57 months after their expiration [10].
An extreme case concerns Phenytoin (Dilantin), an
anti-seizure medication, which remains effective for 20
years following its expiration. On the other hand, some
drugs, such as antibiotics, blood thinners, and
chemotherapy drugs can become toxic and hazardous
to human health and the environment if they are not
disposed of properly [11]. Thus, effective practices to
reduce drug waste include not only improving the use
of drugs, but also the effective disposal of
expired/unwanted drugs. In sum, it is urgent to reduce
preventable medicine waste and to dispose effectively
of inevitable medicine waste. This concerns the
practices of drug logistics, drug household
management, and medication management. These
practices involve a large number of heterogeneous
actors such as pharmaceutical manufacturers,
wholesalers, retailers, logistics providers, general
practitioners, community pharmacies, government, and
consumers. These actors, together with their relations
and interactions, constitute a complex socio-technical
system.
Recently, IS researchers have described such
dynamic
complex
systems
as
information
infrastructures (IIs) by defining IIs as shared, open
(and unbounded), heterogeneous and evolving sociotechnical systems [12]. However, there is very little
research on how to connect practices which, so far, are
entirely unrelated to one another. The literature focuses
on cases where an information infrastructure grows
gradually through extension ‘at the edges’ driven by
user communities and enabled by modular and flexible
designs (ibid.). However, information infrastructures
may also develop in a more discontinuous,
‘punctuated’ manner [13]. This suggests that an
information infrastructure may also emerge when three
or more practices become related to one another which,
so far, were unrelated. Drawing on a physics metaphor,
the bringing together of several, so far unrelated
practices may be sufficient to create a ‘boiling point’
where matter changes from one aggregate state to
another. In this paper we therefore explore the
facilitators and inhibitors of bringing together the three
practices of waste drug recycling, medication
management, and household drug management in order
to understand the conditions under which the
development of an information infrastructure,
understood as an emergent phenomenon triggered by a
re-configuration of practices, can happen.

We begin by presenting the literature on waste drug
recycling, medication management and household drug
management and also briefly summarize the literature
on information infrastructure development. Next, we
describe and analyze the current situation of drug
waste management in China and outline the barriers to
extending and broadening these practices and systems.
The fourth section explores the possibilities and
problems of connecting the three practices concerned:
waste drug recycling, medication management, and
household drugs management. We argue that by
connecting the three practices the preconditions for the
emergence of an innovative information infrastructure
that supports expired drugs recycling can be created.

2. Literature review
2.1. Waste drug recycling and drug review/
management systems
To protect the environment, reduce economic loss
and increase the safety of drug use, several
international organizations have produced guidance
information on managing waste medicines and on drug
and medication review procedures [14, 15]. Some
researchers advocate that an effective and welldesigned household waste drug recycling system can
reduce avoidable waste medicines and effectively
disposes of inevitable waste [1]. Kongar, Haznedaroglu
[16] proposed a radio frequency identification-based
information technology infrastructure for reverse
logistics of end-of-life drugs products.
Although industries have various levels of
involvement with waste drug recycling applications,
such practices are regarded as difficult as they
complicate the traditional forward-oriented medicine
supply chain [17]. Recycling of waste medicines is
challenging and difficult to implement because no
commercial value can be recaptured from waste
medicines. This causes hesitation and reluctance of the
actors in the medicine supply chain to implement
recycling processes [18]. This is quite a significant
finding because it, in turn, inhibits initiatives to invest
in the recycling infrastructure and related information
systems and limits the scope for collaboration among
actors. However, recycling packing materials, reuse of
good condition medicines, sorting and separating
processes of returned medicines etc. have become
feasible practices to create residual value.
As a result of strict regulations and health and
safety concerns, effective use and management of
drugs have also become important for reducing
avoidable waste, such as intervention and guidance in
drug use, standardization of medicine package sizes,
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improving prescribing patterns, and storage
management within household. With regard to waste
drug management practices, the NHS (UK) in 2012
launched an action plan to determine how best
practices can be shared to improve the use of
medicines and to address medicine waste within the
NHS [15]. The report also shows how improvements in
the use of drugs have become an important part in the
recycling of waste drugs.
With regard to research on medication reviews and
management, in 2016 the Pharmaceutical Care
Network Europe (PCNE) defined medication review as
a structured evaluation of a patient’s medicines with
the aim of optimizing medicine use and improving
health outcomes [14]. This entails detecting drug
related problems and recommending interventions with
regard to treatment effectiveness and avoidance of
adverse drug events.
The main objective of drug management is to
reduce financial expenditure, avoid waste, increase
access, and ensure that drugs are properly used [19].
The so-called drug management cycle includes
selection, procurement, storage and distribution, and
use [20]. In the household context, drug management
includes consumers’ selection, purchase, storage, use,
and disposal of drugs. Among these, the last item is
related to drug recycling and the others are related to
the medication review.

2.2. Information infrastructure development
The literature on information infrastructure design
and development is largely in agreement with Hanseth
and Lyytinen [12] characterization of information
infrastructure as an open, shared, heterogeneous, and
evolving socio-technical system. On this view, the
development of an information infrastructure is not
merely a switch between an old and a new information
infrastructure, but a gradual and step-wise transition.
Information infrastructure evolution is seen as an
incremental, emergent process from simpler to more
complex forms. Various authors have emphasized
different aspects, such as the importance of standards
[21], of the installed base [22], of modularity [23], of
the role of users as designers [24], the flexibility of
information infrastructure [25, 26], the role of
governance structures [27], and the role of materiality
[28]. However, the early emphasis on practices, as is
evident in the foundational paper by Star and Ruhleder
[29] has been largely lost. A view of information
infrastructure as a constellation of practices has been
proposed in the literature [30, 31] but not yet been
widely adopted.

3. The current situation of household waste
drugs recycling in China
In China, the recycling of expired drugs is still in
an early stage. Some enterprises and governments at
the local level are actively exploring and practicing
different drug recycling models. These recycling
models can be divided into two categories depending
on who is the responsible actor, a pharmaceutical
manufacturer (see Figure 1) or government (see Figure
2).
Incineration plant

Pharmaceutical manufacturer
Supervision Government
Drug stores

Community

Internet pharmacy

OFFLINE

ONLINE

Consumers
Figure 1. Pharmaceutical enterprise-led
recycling for household waste drugs
Incineration plant
Government

Medical
Association

Environmental
Organizations

Pharmaceutical/Pharm
acist Association

Community
service
center
OFFLINE

Health related service
Consumers
Figure 2. Government-led recycling for
household waste drugs
A typical example of the pharmaceutical enterpriseled recycling model concerns the system set up by
Guangzhou Baiyunshan Pharmaceutical Holdings
(GBPH). Since the launch of an activity called “family
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expired drugs collection” in 2003 GBPH has carried
out the activity regularly every year. Over the last 15
years, the company’s recycling activities have been
continuously extended. These extensions concern:
• the range of participating enterprises (from
initially a single company to the whole group),
• the scope of operations (from a single locality
to more than 200 cities nationwide),
• the number of participating drugstores (from
initially five to more than 6000 pharmacies and
community medical institutions),
• the reach of the service (from the doctor’s
waiting room to door-to-door visits for lonely
elders in designated communities),
• the areas covered (from urban to rural),
• and the mode of recycling (from offline to
online).
With the increasing awareness of the risks posed by
expired drugs, more and more local governments have
launched household expired drugs recycling activities
and have made remarkable achievements in the
improvement of recycling systems and the construction
of expired drug collection points. Local governments
have used various community centers as collection
points for expired drugs. These collection points not
only collect waste medicines but also provide some
health-related service.
Despite such constant efforts there are still
significant limitations concerning the existing models
for recycling expired drugs. Table 1 shows the
problems identified.
Table1. Problems identified
Stakeholder
Problems identified
Waste drug recycling Residual value is lacking
enterprises
Recycling costs are high
Pharmacists and
Enthusiasm is low
doctors
Consumers
Collection points are
limited
Awareness is low
Enthusiasm is low
Trust is low
Governments
Supervision is difficult
Firstly, there is no commercial value left in the
current waste drug recycling system and the costs of
recycling and disposal are very high; for example,
GBPH invests tens of millions for its recycling activity
every year [32]. Most of waste drugs have been
collected in traditional ways and directly incinerated.
This kind of model cannot recapture any value from
returned drugs. Thus, there is only a very small number
of large pharmaceutical companies carrying out

recycling for a limited duration and with a limited
range.
Secondly, there is no motivation for pharmacists
and doctors to get involved in recycling activities. In
government-led models, although the government is
trying to ask pharmacists and doctors to provide
health-related services in some community centers,
there is no effective compensation mechanism. The
activities are only known as charity.
Thirdly, consumers’ awareness of possibilities to
recycle drugs is low, together with the lack of
incentives and of information sharing, which reduces
consumers’ willingness to contribute to drug recycling
and their trust in recycling enterprises.
Finally, the lack of a tracking system makes it
difficult for government to supervise drug recycling,
leading to increases in the number of counterfeit drugs
and creating an opening for a “grey” market for
expired drugs to emerge. This has a negative impact on
the environment, the financial situation of
manufacturers, and causes social and health problems.
However, it seems that the current models offer
some levers to improve this situation. In the
manufacturer-led model, GBPH has begun to adopt an
online model for recycling and is building consumers’
electronic health profiles for some special groups (e.g.,
the elderly) since 2015. With the development of drug
QR codes in China, possibilities for electronic
management of expired drugs recycling and drug
management are shaping up. Government is also trying
to provide more health-related services in its own
model. To improve consumers’ awareness for the
environment and their health, various specialists (e.g.,
pharmacists, environmental experts) provide drug and
environment-related knowledge and advice. Thus,
medication management is showing its role in the
waste drug recycling process.
However, these practices have so far failed to
evolve into an effective system for expired drugs
recycling because they are not yet connected to each
other. Following the clues provided by our analysis so
far, we formulate:
Proposition 1. Effective practices for drug
recycling require multi-actor involvement and crosspractice collaboration among the involved actors.
Considering the dynamic complexity involved in
such an undertaking, we portray an evolutionary
process from a single to a triple-practice system which
could lead to the emergence of an information
infrastructure that connects the practices of waste drug
recycling, drug management, and medication
management.

Page 4003

4.
Emergence
of an
information
infrastructure resulting from connecting
the three practices
4.1. Information infrastructure as a constellation of aligned practices
As described above (see Section 2.2), information
infrastructures are commonly defined as evolving
complex systems consisting of heterogeneous technical
and social components and as being characterized by
an in principle unbounded functional scope and
societal reach. However, information infrastructures
continue to be understood as essentially socio-technical
systems with some technical components at their core.
By contrast, Star and Ruhleder [29] have argued for a
practice-based
understanding
of
information
infrastructure, a proposal which has not yet been
widely appropriated in the literature. For our purposes,
however, a practice-based approach offers unique
advantages as it allows for an understanding of an
information infrastructure as a set or ‘constellation’ of
aligned practices [30, 31]. On such a view, an
information infrastructure emerges or evolves through
many small-scale changes in related practices so that
relevant information can start to flow more easily
across these practices. For example, in most practices
the use of computers for information storage and
processing is quite common. However, sharing such
information across practices often encounters formal
and informal barriers. A traditional information
systems approach would call for the definition of clear
interface specifications so that information can flow
more efficiently between related systems. However, a
practice-based approach opens up many more
possibilities, not all of which are technical in nature.
Oftentimes, miniscule adaptations in system settings,
coding procedures or data maintenance operations may
be all that is needed in order to improve the flow of
information across practices. While such changes may
appear as insignificant and trivial when taken
individually, in sum they may have far reaching effects.
Discovering such opportunities for adaptation,
however, is not an easy task. Members of one practice
may have to improve their awareness and
understanding of how related practices operate and
‘function’. Thus, a better mutual understanding of
related practices may be the most important first step
towards making the many small-scale changes that,
together, lead to the evolution or emergence of an
information
infrastructure,
understood
as
a
constellation of aligned practices. In the following we
are guided by this understanding of information
infrastructure which takes as its point of departure not

a technical system that needs to be connected with
other technical systems but a practice that needs to be
better aligned with related practices.

4.2. Methodological approach
Due to the growing need for coordination and
collaboration among various actors, the process of
information infrastructure evolution and emergence is
characterized by a high degree of unpredictability.
Gray and Hovav [33] have introduced the use of
scenarios to the IS field to address such uncertainty.
Specifically, they argue that scenarios provide a
legitimate and practical “way of communicating about
the future” (1999, p. 15). Scenarios are not to be
confused with predictions; rather, they help managers
and politicians to understand the assumptions and
implications of various possible courses of actions and
thus to prepare for the future without having to predict
it (1999, p. 15).
Identifying key drivers is crucial for creating a
scenario space [33]. In the following, we will apply
this insight to develop a plausible scenario for evolving
an information infrastructure for recycling expired
drugs based on the assumption that such evolution is
driven by the possibilities that result from connecting
the involved practices in multiple ways. We will
develop this scenario in three steps by gradually
extending the number of connections between the three
practices.

4.3. Single practice scenario
The first scenario views the three practices of waste
drug recycling, household drug management, and
medication management as independent and
unconnected, as shown in Figure 3. This represents the
current situation.

Waste drug
recycling

Household
drug
management

Medication
management

Figure 3. Three independent practices
4.3.1. Waste drug recycling. Waste drug recycling
involves manufacturers, wholesalers, retailers, logistics
providers, and consumers. The objective of the system
is to recycle the expired drugs from consumers. Based
on some experiences in some developed countries,
returned drugs are special types of end-of life (EoL) or
end-of-use (EoU) returns of consumer goods [34].
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Some waste medicines, as EoU returns, still preserve
functionality intact and are capable of being reused
[35]. Package-related returns bring some residual value
and create useful information which can influence the
package sizes, shapes, materials used and so on. Drug
recycling enterprises optimize the package design to
protect products properly and allow consumers to use
the product safely.
Electronic order management is beneficial for
logistics companies to optimize transportation, for
manufacturers and wholesalers to obtain expired drugrelated data to guide pharmaceutical research,
development, design, and sales.
Retailers, as collection points, interact directly with
consumers. By integrating consumers’ purchase
records with recycling records, they can offer
personalized recommendations and improve quality of
service. In some cases, retailers provide promotional
activities, such as discount coupons, bonuses, etc. to
improve consumers’ awareness of possibilities to
return expired drugs.
However, these measures provide only limited
value for participants. Due to strict regulations and
health and safety concerns, the impact of actual cost
savings per returned product for waste drugs recycling
management is small [8]. Sorting and separating
processes for returned medicines can be complex, and
often only a minority of products are intact, in good
condition and in shelf life [8]. This means that the
extent to which reuse of medicines can affordably
reduce the costs of medicine waste is likely to be very
small. Thus, it is crucial to find more complementary
measures to improve the motivation of waste drugs
recycling enterprises. More effective savings would be
generated from improved use of drugs [15], greater
standardization of medicine package sizes, and
improved prescribing patterns [1], all of which would
reduce avoidable waste in a cost-effective manner.
4.3.2. Household drug management. Household drug
management is related to consumers. Consumers can
manage their own drugs, such as inputting drug
information
into
a
computerized
inventory
management system and obtaining basic instructions
from drug booklets about classification, precautions
and so on. However, due to the special nature of drugs,
especially health and environmental risks associated
with drug use, it is important that professional actors
(e.g. pharmacists or doctors) provide effective drug use
instruction and help.
4.3.3. Medication management. Pharmacists and
doctors adopt medication management systems to
evaluate and intervene in patients’ medication with
regard to treatment effectiveness and avoidance of

adverse drug events. Thus, drug use-related
information is an important resource for these two
actors’ medication management. However, in the
independent system context, this information is rare
because it comes from external sources, such as
manufacturers and consumers.

4.4. Two-practice scenario
The second scenario shows the interaction between
any pair of practices through sharing information and
providing service to create incentives for participants
in these practices, as shown in Figure 4.
Drug recycling
service
Expired drugs

Household
drug
management

A

A
C

B

Waste drug
recycling

Drug use
service

D

Medication
management

E
Information flow

service flow

A: consumer’s unexpired/expired/unwanted
drug information
B: recycling information, e.g., collection
points, how to dispose of expired drugs
C: drug use information, e.g. how to use, store,
and dispose of drugs
D: expired drugs
E: practical efficacy of drugs
Figure 4. The interaction between pairs of two
practices
4.4.1. Waste drug recycling and household drug
management. In scenario 1, waste drug recycling only
focuses on collection and disposal of expired drugs.
The value of such a system is likely to be small.
Research findings suggest that waste drugs recycling
cannot happen unless the consumer is compliant and
becomes involved, e.g. to return the expired/unwanted
drugs to the collection points [36]. In waste drugs
recycling, the role of the consumer is not only as a
consumer of drug/medication services, but also as an
actor to reduce unneeded drugs and to return the
unwanted drugs. Consumers’ expectations towards
receivers accepting these returns form an important
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noneconomic aspect of consumer service [37].
Consumers need to be educated to manage unwanted
medication differently, e.g. to bring the drugs to a
collection site or hazardous waste facility rather than
dispose of medication into water or domestic waste
systems.
In scenario 2, through connecting household drugs
management and waste drug collection practices, waste
drugs recycling can provide recycling related
information, e.g. at the collection point, reminding
patients of a drug’s expiration date and proper ways of
disposal, which can have a significant influence on
increasing product returns from consumers and reduce
recycling costs and the waste itself. Further, waste
drugs recycling enterprises can obtain information
about unexpired/unwanted drugs from consumers that
further guide drug research, development, design and
sales.
Consumers can be offered more effective recycling
waste drugs service. The drugs recycling enterprises
provide offline and online collection channels.
Consumers can find the nearest collection point to send
waste drugs to or order expired drugs pick-up in their
homes online. Consumers can track the process of drug
disposal and share drug-related information, which
improves consumers’ trust and involvement.
Proposition 2. The connection between waste
drugs recycling and household drug management
practices has a significant positive impact on reducing
recycling costs and waste and promotes consumers’
involvement and trust.
4.4.2. Waste drug recycling and Medication
management. In scenario 1, for independent
medication management it is difficult to obtain drugrelated information because the information comes
from external sources, such as manufacturers and
consumers. Manufacturers have the initial instruction
regarding drug usage and consumers have experiences
with drugs. Waste drug management produces much
valuable information related to expired drugs. The
information is also an important resource for
medication management. For example, based on the
causes of expired drugs, doctors can improve
prescribing patterns and pharmacists can provide
effective advice to reduce waste.
In addition, the independent waste drug recycling
enterprises, e.g. manufacturers, are particularly
concerned about the practical efficacy of drugs because
this is directly related to their pharmaceutical research,
development and sales.
Proposition 3. The connection between waste
drugs management and medication management has a
significant positive impact on improving the efficacy
and effective use of drugs.

4.4.3. Household drug management and Medication
management. As an indispensable resource,
consumers’ drug and drug use-related information has
a significant influence on medication management.
Household drugs management provides unexpired and
expired drug information which helps pharmacists
make more effective evaluation and give better
medication advise. In turn, effective drug-related
guidance, e.g. how to use, store, and dispose of the
drugs, raises consumers’ awareness of the impact of
drugs on the environment and their health, which
increases the willingness of patients to return drugs and
to reduce waste. There is a need to increase consumers’
loyalty for the success and sustainability of medication
management.
Proposition 4. The connection between household
drug management and medication management has a
significant positive impact on improving the effective
use of drugs and consumers’ awareness of
environmental and health risks associated with drug
use.

4.5. Three-practice scenario
In scenario 3, a platform emerges which simplifies
information sharing among the three practices,
strengthens and enriches interactions among them, and
draws in further actors (e.g., government and
environmental protection organizations), as shown in
Figure 5.

Figure 5. The three-practice scenario
In scenario 2, although the interaction between any
pair of two practices is beneficial to each participant,
the redundancy of information and the complexity of
communication act as barriers for the creation of
further connections between practices. For all
information, each role needs to share and communicate
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with others separately; for example, consumers’ drug
information is transferred to waste drug recycling and
medication management separately. By contrast, the
three-practice scenario opens up a space for many
more connections as a platform emerges which also
has the potential to pull in further actors such as
government
and
environmental
protection
organizations.
All of the participants need more and better drugrelated information to realize their own objectives. For
“creating” residual value, reducing waste and cost,
waste drugs recycling enterprises need to obtain drugrelated information from both household drugs and
medication management. Correspondingly, for
improving effective use of drugs there is a need to
obtain more drug use-related information from
manufacturers and consumers. Consumers’ unexpired
and expired drugs need to be managed effectively by
both recycling enterprises and pharmacists. Thus, it
becomes important to create additional connective
ways between the three practices to strengthen and
enrich their communication and collaboration. A
platform will emerge from pairs of connections to
integrate redundant information and enrich interactions
among all actors. For example, information on how to
effectively use a drug or a class of drugs, how to
dispose of drugs, and on drug quality certification
could be shared among all participants. At the same
time, information security and privacy protection
caused by information sharing can be addressed more
effectively.
In addition, the three-practice scenario not only
expands existing services and the user base but also
increases its scope and reach by including new actors.
For example, government can now realize a more
effective supervision to strengthen drug safety,
information security, and privacy protection because of
better integration of unexpired/expired drugs
information and medication management. Moreover, in
recent years environmental protection organizations
have become more concerned about expired drugs and
their possible negative impact on soil and water
because pharmaceutical contamination is becoming
ubiquitous in the environment. As pharmaceutical
contamination cannot be effectively removed from
wastewater by conventional methods, the occurrence of
expired drugs has received increasing attention by
environmental protection organization [38]
Proposition 5. As the number of connections
between practices increases, a platform emerges that
simplifies and enriches the connections between all
three practices and thus creates even more possibilities
for expanding existing services and the user base,
including opportunities to increase the scope of the
network and the range of stakeholders.

5. Conclusions
Our analysis and scenarios have shown that there is
a significant potential to increase the motivation for all
actors concerned with expired drugs recycling by
connecting the three involved practices of waste drug
recycling, medication management, and household
drug management in manifold ways. From a practical
perspective, connecting the three practices in this
manner would greatly contribute to effectively
addressing a growing problem and burden for the
environment resulting from increasing usage of
medicines by an aging and more affluent population.
From a theoretical perspective, our analysis suggests a
novel mechanism for information infrastructure
emergence.
While
information
infrastructure
development has so far been portrayed as primarily
driven through growth at the periphery, mostly through
user activity enabled by modular and flexible designs,
an information infrastructure may also emerge de novo
as a result of connecting so far unrelated practices in a
sufficiently rich and multi-directional manner, similar
to the phenomenon of state transitions known from
physics. Our scenarios show how such a ‘phase
transition’, i.e. the phenomenon of emergence, might
come about for the case of information infrastructures.
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